Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sphingolipidoses.

F M Yatsu

    California Medicine
    |April 1, 1971
    PubMed
    Summary
    This summary is machine-generated.

    Sphingolipidoses are inherited metabolic disorders affecting the central nervous system, primarily in children. Diagnosis is possible during pregnancy and after birth, aiding genetic counseling.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Dipyridamole plus aspirin versus aspirin alone in secondary prevention after TIA or stroke: a meta-analysis by risk.

    Journal of neurology, neurosurgery, and psychiatry·2008
    Same author

    Butyrate inhibits proliferation-induced proliferating cell nuclear antigen expression (PCNA) in rat vascular smooth muscle cells.

    Molecular and cellular biochemistry·2000
    Same author

    HMG-CoA reductase inhibitors (statins): a promising approach to stroke prevention.

    Neurology·2000
    Same author

    Is cholesterol a risk factor for stroke?: Yes.

    Archives of neurology·1999
    Same author

    Intravenous tissue plasminogen activator for acute ischemic stroke: feasibility, safety, and efficacy in the first year of clinical practice.

    Stroke·1998
    Same author

    Inhibition of platelet-derived growth factor BB-induced expression of glyceraldehyde-3-phosphate dehydrogenase by sodium butyrate in rat vascular smooth muscle cells.

    Arteriosclerosis, thrombosis, and vascular biology·1998
    Same journal

    Observations on mass x-ray surveys.

    California medicine·2010
    Same journal

    Health education and the democratic process.

    California medicine·2010
    Same journal

    Evolution of chemotherapy in tuberculosis.

    California medicine·2010
    Same journal

    Trends of tuberculosis association programs.

    California medicine·2010
    Same journal

    The treatment of subacute bacterial endocarditis.

    California medicine·2010
    Same journal

    [CASE history: polyarteritis nodosa with massive involvement of the kidney masqueraded as acute glomerular nephritis].

    California medicine·2010
    See all related articles

    Area of Science:

    • Biochemistry
    • Genetics
    • Pediatrics
    • Neurology

    Background:

    • Sphingolipidoses are a diverse group of inherited lipid metabolism disorders.
    • These conditions primarily impact the central nervous system, particularly in pediatric patients.
    • They are characterized by progressive neuronal degeneration affecting gray and white matter.

    Purpose of the Study:

    • To summarize the nature of sphingolipidoses.
    • To highlight the specific enzyme deficiencies identified in various sphingolipidoses.
    • To emphasize the diagnostic capabilities and implications for genetic counseling.

    Main Methods:

    • Biochemical analysis to identify specific lysosomal enzyme defects.
    • Clinical observation of neurological symptoms (psychomotor retardation, spasticity).

    Related Experiment Videos

  • Review of diagnostic methods for antepartum and postpartum identification.

    • Main Results:

    • Specific enzyme deficiencies identified: sphingomyelinase (Niemann-Pick), galactocerebrosidase (Krabbe's), beta-D-glucosidase (Gaucher's), sulfatase (metachromatic leukodystrophy), hexosaminidase A (Tay-Sachs), beta-galactosidase (generalized gangliosidosis).
    • Understanding of the progressive neurological damage in affected children.
    • Confirmation of the feasibility of definitive diagnosis before and after birth.

    Conclusions:

    • While curative therapies are unavailable, precise diagnosis of sphingolipidoses is achievable.
    • Accurate diagnosis facilitates informed genetic counseling for affected families.
    • Further research into therapeutic interventions remains crucial.